Wen-Rong Jiang

Jan 8, 2025 | outsourcedpharma.com | Michiel Stam |Louis Garguilo |Wen-Rong Jiang |JOINN Biologics

We’re ready to help usher your next drug into market! 2025’s first Outsourced Pharma Capacity Update provides a unique, virtual experience and the details necessary to find a CDMO for your specific timeline, volume, and production needs. Join us the last week of January as we draw the curtains on the industry’s best and give you complimentary VIP access to the resources available to support your success.

Oct 7, 2024 | bioprocessonline.com | Ioanna Deni |Wen-Rong Jiang |JOINN Biologics

Webinar: The Way Forward: Supply Chain SolutionsJoin us on October 24th as Thermo Fisher Scientific explores supply chain optimization solutions and best practices to avoid disruptions that can lead to material delays and increased costs. Learn how to enhance strategic planning for your critical chemicals and pre-production operations and discover programs that provide cost, time, and resource savings.

Sep 26, 2024 | outsourcedpharma.com | Louis Garguilo |Malorie Meyer |Wen-Rong Jiang |JOINN Biologics

Mabion Capacity Update July 2024: Fill/FinishMabion, a biologics CDMO with end-to-end services focusing on recombinant proteins development and production, showcases new depyrogenation, fill finish vial capabilities, and CMC analytical proficiencies. Nuclear magnetic resonance spectroscopy is powerful technique used to investigate the structure and dynamics of the drug substance in various drug formulations.

Jul 18, 2024 | outsourcedpharma.com | Louis Garguilo |Eric Doerr |JD Williams |Wen-Rong Jiang

Mabion Capacity Update May 2024: Large Molecule DevelopmentReview our installations in upstream development, downstream development, and fill & finish. Our state-of-the-art EU-GMP certified facility is staffed by a team of 250 professionals and, as of 2023, is focused solely on providing CDMO services to its clients. Capacity is now available and our team is excited to engage in new projects.

Jun 17, 2024 | bioprocessonline.com | Sami Ullah |Juliana Bischof |Wen-Rong Jiang |JOINN Biologics

Webinar: A next-generation medium and feeds system to improve productivity in CHO cell linesLearn about the benefits of a next generation CHO medium and feeds system to support performance improvements in CHO-K1, CHO-K1 GS, CHO-S, and DG44 cells, including improved production capability and protein quality, sustained cell viability and more. Presenters will detail results from the use of this chemically defined offering designed with an innovative multi-omics based approach.